Your browser doesn't support javascript.
loading
A patient-based murine model recapitulates human STAT3 gain-of-function syndrome.
Meesilpavikkai, Kornvalee; Zhou, Zijun; Kaikaew, Kasiphak; Phakham, Suphattra; van der Spek, Peter J; Swagemakers, Sigrid; Venter, Deon J; de Bie, Maaike; Schrijver, Benjamin; Schliehe, Christopher; Kaiser, Fabian; Dalm, Virgil A S H; van Hagen, P Martin; Hirankarn, Nattiya; IJspeert, Hanna; Dik, Willem A.
Afiliación
  • Meesilpavikkai K; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Zhou Z; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Kaikaew K; Center of Excellence in Alternative and Complementary Medicine of Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Phakham S; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • van der Spek PJ; Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Swagemakers S; Department of Pathology and Clinical Bioinformatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Venter DJ; Department of Pathology, Mater Health Services, Brisbane, Queensland, Australia.
  • de Bie M; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Schrijver B; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Schliehe C; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Kaiser F; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Dalm VASH; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Hagen PM; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Allergy & Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: p.m.vanhagen@eras
  • Hirankarn N; Center of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: Nattiya.h@chula.ac.th.
  • IJspeert H; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Dik WA; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: w.dik@erasmusmc.nl.
Clin Immunol ; 266: 110312, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39019339
ABSTRACT
STAT3 gain-of-function (GOF) variants results in a heterogeneous clinical syndrome characterized by early onset immunodeficiency, multi-organ autoimmunity, and lymphoproliferation. While 191 documented cases with STAT3 GOF variants have been reported, the impact of individual variants on immune regulation and the broad clinical spectrum remains unclear. We developed a Stat3p.L387R mouse model, mirroring a variant identified in a family exhibiting common STAT3 GOF symptoms, and rare phenotypes including pulmonary hypertension and retinal vasculitis. In vitro experiments revealed increased STAT3 phosphorylation, nuclear migration, and DNA binding of the variant. Our Stat3p.L387R model displayed similar traits from previous Stat3GOF strains, such as splenomegaly and lymphadenopathy. Notably, Stat3p.L387R/+ mice exhibited heightened embryonic lethality compared to prior Stat3GOF/+ models and ocular abnormalities were observed. This research underscores the variant-specific pathology in Stat3p.L387R/+ mice, highlighting the ability to recapitulate human STAT3 GOF syndrome in patient-specific transgenic murine models. Additionally, such models could facilitate tailored treatment development.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / Factor de Transcripción STAT3 / Mutación con Ganancia de Función Límite: Animals / Female / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Modelos Animales de Enfermedad / Factor de Transcripción STAT3 / Mutación con Ganancia de Función Límite: Animals / Female / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Estados Unidos